J&J in talks to buy Synthes for $20-billion: WSJ

The company attempted to acquire U.S. medical device maker Guidant several years ago, but was outbid by Boston Scientific Corp. ���J&J has developed a strong war chest of cash. They have the ability to do a deal like this from a size and strategy...